amlodipine + irbesartan + hydrochlorothiazide

Standard medical therapy-Shanghai Jiao Tong University School of Medicine-hypertension refers to a specific standardized antihypertensive treatment protocol evaluated by the Shanghai Jiao Tong University School of Medicine. This protocol utilizes a sequential, stepped-care approach involving three primary antihypertensive agents: amlodipine (a calcium channel blocker), irbesartan (an angiotensin II receptor blocker), and hydrochlorothiazide (a thiazide diuretic). The regimen begins with amlodipine 5 mg, escalating to amlodipine 5 mg plus irbesartan 150 mg, then to amlodipine 10 mg plus irbesartan 300 mg, and finally adding hydrochlorothiazide 12.5 mg if blood pressure targets are not met. It is designed to provide a simple, effective treatment strategy for uncontrolled hypertension in the Chinese clinical setting.

Other names

Standardized Antihypertensive Treatment Protocolstandard medical therapy-Shanghai Jiao Tong University School of Medicine-hypertension